Randomized phase III trial results of Panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer

Tara Beers Gibson, Aarati Ranganathan, Axel Grothey

Research output: Contribution to journalReview articlepeer-review

134 Scopus citations

Fingerprint Dive into the research topics of 'Randomized phase III trial results of Panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences